Cencora, Inc. (COR)

↓ Download CSV

CIK 0001140859 · NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries

  • Sector Wholesale Trade
  • Incorporated DE
  • Fiscal year ends Sep 30

In fiscal 2025, Cencora, Inc. reported revenue of $321.33B, up 9.3% from the prior year. The company was profitable, with a net margin of 0.5% and a gross margin of 3.6%.

Key ratios (FY2025)

3.6%
Gross margin
0.8%
Operating margin
0.5%
Net margin
103.1%
Return on equity
+9.3%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$321.33B$293.96B$262.17B$238.59B$213.99B$189.89B$179.59B$167.94B$153.14B$146.85B
Cost of Revenue$309.85B$284.05B$253.21B$230.29B$207.05B$184.70B$174.45B$163.33B$148.60B$142.58B
Gross Profit$11.48B$9.91B$8.96B$8.30B$6.94B$5.19B$5.14B$4.61B$4.55B$4.27B
Operating Income$2.63B$2.18B$2.34B$2.37B$2.35B-$5.14B$1.11B$1.44B$1.06B$1.53B
Net Income$1.55B$1.51B$1.75B$1.70B$1.54B-$3.41B$855.37M$1.66B$364.48M$1.43B
EPS (Diluted)$7.96$7.53$8.53$8.04$7.39$-16.65$4.04$7.53$1.64$6.32
Total Assets$76.59B$67.10B$62.56B$56.56B$57.34B$44.27B$39.17B$37.67B$35.32B$33.64B
Shareholders' Equity$1.51B$645.94M$522.00M-$211.56M$223.35M-$1.02B$2.88B$2.93B$2.06B$2.13B
Cash & Equivalents$4.36B$3.13B$2.59B$3.39B$2.55B$4.60B$3.37B$2.49B$2.44B$2.74B
Operating Cash Flow$3.88B$3.48B$3.91B$2.70B$2.67B$2.21B$2.34B$1.41B$1.50B$3.18B
Capital Expenditures$667.98M$487.17M$458.36M$496.32M$438.22M$369.68M$310.22M$336.41M$466.40M$464.62M
Shares Outstanding195.21M200.28M204.59M211.21M208.47M204.78M211.84M220.34M221.60M225.96M
Dividends Per Share$2.20$2.04$1.94$1.84